Global Immunoassay Reagents and Devices Market - Industry Trends and Forecast To 2027

1 INTRODUCTION 34

1.1 OBJECTIVES OF THE STUDY 34

1.2 MARKET DEFINITION 34

1.3 OVERVIEW OF GLOBAL IMMUNOASSAY REAGENTS AND DEVICES MARKET 35

1.4 CURRENCY AND PRICING 37

1.5 LIMITATIONS 37

1.6 MARKETS COVERED 37

2 MARKET SEGMENTATION 41

2.1 MARKETS COVERED 41

2.2 GEOGRAPHICAL SCOPE 42

2.3 YEARS CONSIDERED FOR THE STUDY 43

2.4 DBMR TRIPOD DATA VALIDATION MODEL 44

2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 47

2.6 DBMR MARKET POSITION GRID 48

2.7 DBMR VENDOR SHARE ANALYSIS 49

2.8 MULTIVARIATE MODELING 50

2.9 PRODUCT TIMELINE CURVE 50

2.10 SECONDARY SOURCES 51

2.11 ASSUMPTIONS 51

3 EXECUTIVE SUMMARY 52

4 PREMIUM INSIGHTS 56

4.1 INDUSTRY INSIGHT 57

5 MARKET OVERVIEW 58

5.1 DRIVERS 60

5.1.1 INCREASING PREVALENCE OF DISEASES 60

5.1.2 INCREASING APPLICATION OF DRUG SCREEINING TESTS 60

5.1.3 INCREASING HEALTHCARE EXPENDITURE 61

5.1.4 WIDE APPLICATION OF IMMUNOASSAY 62

5.2 RESTRAINTS 63

5.2.1 PRODUCT RECALL OF IMMUNOASSAY KITS AND DEVICES 63

5.2.2 STRINGENT REGULATIONS BY REGULATORY AUTHORITIES 64

5.2.3 HIGH COST ASSOCIATED WITH DEVICES 65

5.3 OPPORTUNITIES 66

5.3.1 INCREASE IN RESEARCH & DEVELOPMENT ACTIVITIES 66

5.3.2 STRATEGIC INITATIVES BY THE COMPANIES 67

5.3.3 TECHNOLOGICAL UPGRADATION AND ADVANCEMENTS IN BIOTECHNOLOGY 67

5.4 CHALLENGES 68

5.4.1 LACK OF AWARENESS AND SKILLS REGARDING THE USAGE OF TECHNOLOGY 68

5.4.2 COMPLEXICITY IN PERFORMING IMMUNOASSAY 69

5.4.3 AVAILABILITY OF SUBSTITUTE 70

6 GLOBAL IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT 71

6.1 OVERVIEW 72

6.2 REAGENTS & KITS 73

6.2.1 ELISA REAGENTS & KITS 73

6.2.1.1 THIRD-GENERATION ELISA 74

6.2.1.2 FIFTH-GENERATION ELISA 74

6.2.1.3 FOURTH-GENERATION ELISA 74

6.2.1.4 FIRST-GENERATION ELISA 74

6.2.1.5 SECOND-GENERATION ELISA 74

6.2.2 ELISPOT REAGENTS & KITS 74

6.2.3 RAPID TEST REAGENTS & KITS 74

6.2.4 WESTERN BLOT REAGENTS & KITS 74

6.2.5 OTHER REAGENTS & KITS 75

6.3 ANALYZERS 75

6.3.1 BY TYPE 75

6.3.1.1 OPEN-ENDED SYSTEMS 75

6.3.1.2 CLOSED-ENDED SYSTEMS 76

6.3.2 BY DEVICE TYPE 76

6.3.2.1 BENCH-TOP 76

6.3.2.2 FLOOR STANDING 76

7 GLOBAL IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM 77

7.1 OVERVIEW 78

7.2 ENZYME IMMUNOASSAY 79

7.3 FLUORESCENCE IMMUNOASSAYS 80

7.4 CHEMILUMINESCENCE IMMUNOASSAYS 80

7.5 RADIOIMMUNOASSAYS 81

7.6 OTHERS 82

8 GLOBAL IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE 83

8.1 OVERVIEW 84

8.2 ENZYME-LINKED IMMUNOSORBENT ASSAYS 85

8.3 ENZYME-LINKED IMMUNOSPOT 86

8.4 RAPID TESTS 86

8.5 WESTERN BLOTTING 87

8.6 IMMUNO-PCR 88

8.7 OTHER TECHNIQUES 88

9 GLOBAL IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE 89

9.1 OVERVIEW 90

9.2 BLOOD 91

9.3 URINE 91

9.4 SALIVA 92

9.5 OTHERS 93

10 GLOBAL IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION 94

10.1 OVERVIEW 95

10.2 ONCOLOGY AND ENDOCRINOLOGY 96

10.3 HEMATOLOGY & BLOOD SCREENING 97

10.4 CARDIOLOGY 97

10.5 INFECTIOUS DISEASES 98

10.6 BONE & MINERAL DISORDERS 99

10.7 AUTOIMMUNE DISORDERS 99

10.8 TOXICOLOGY 100

10.9 NEONATAL SCREENING 100

10.10 OTHER APPLICATIONS 101

11 GLOBAL IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER 102

11.1 OVERVIEW 103

11.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 104

11.3 CLINICAL LABORATORIES 105

11.4 HOSPITALS 105

11.5 RESEARCH & ACADEMIC LABORATORIES 106

11.6 BLOOD BANKS 106

11.7 OTHERS 107

12 GLOBAL IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY GEOGRAPHY 108

12.1 OVERVIEW 109

12.2 NORTH AMERICA 114

12.2.1 U.S. 121

12.2.2 CANADA 124

12.2.3 MEXICO 127

12.3 EUROPE 130

12.3.1 GERMANY 137

12.3.2 FRANCE 140

12.3.3 U.K. 143

12.3.4 ITALY 146

12.3.5 SPAIN 149

12.3.6 RUSSIA 152

12.3.7 NETHERLANDS 155

12.3.8 SWITZERLAND 158

12.3.9 BELGIUM 161

12.3.10 TURKEY 164

12.3.11 REST OF EUROPE 167

12.4 ASIA-PACIFIC 168

12.4.1 CHINA 175

12.4.2 JAPAN 178

12.4.3 INDIA 181

12.4.4 SOUTH KOREA 184

12.4.5 AUSTRALIA 187

12.4.6 MALAYSIA 190

12.4.7 SINGAPORE 193

12.4.8 THAILAND 196

12.4.9 INDONESIA 199

12.4.10 PHILIPPINES 202

12.4.11 REST OF ASIA-PACIFIC 205

12.5 SOUTH AMERICA 206

12.5.1 BRAZIL 213

12.5.2 ARGENTINA 216

12.5.3 REST OF SOUTH AMERICA 219

12.6 MIDDLE EAST & AFRICA 220

12.6.1 SAUDI ARABIA 227

12.6.2 SOUTH AFRICA 230

12.6.3 EGYPT 233

12.6.4 UAE 236

12.6.5 ISRAEL 239

12.6.6 REST OF MIDDLE EAST & AFRICA 242

13 GLOBAL IMMUNOASSAY REAGENTS AND DEVICES MARKET, COMPANY LANDSCAPE 243

13.1 COMPANY SHARE ANALYSIS: GLOBAL 243

13.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 244

13.3 COMPANY SHARE ANALYSIS: EUROPE 245

13.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 246

14 COMPANY PROFILES 247

14.1 F. HOFFMANN-LA ROCHE LTD 247

14.1.1 COMPANY SNAPSHOT 247

14.1.2 REVENUE ANALYSIS 247

14.1.3 COMPANY SHARE ANALYSIS 248

14.1.4 PRODUCT PORTFOLIO 248

14.1.5 RECENT DEVELOPMENT 249

14.2 BIO-RAD LABORATORIES, INC. 250

14.2.1 COMPANY SNAPSHOT 250

14.2.2 REVENUE ANALYSIS 251

14.2.3 COMPANY SHARE ANALYSIS 251

14.2.4 PRODUCT PORTFOLIO 252

14.2.5 RECENT DEVELOPMENTS 255

14.3 BIOMÉRIEUX SA 256

14.3.1 COMPANY SNAPSHOT 256

14.3.2 REVENUE ANALYSIS 256

14.3.3 COMPANY SHARE ANALYSIS 257

14.3.4 PRODUCT PORTFOLIO 257

14.3.5 RECENT DEVELOPMENT 258

14.4 ABBOTT 259

14.4.1 COMPANY SNAPSHOT 259

14.4.2 REVENUE ANALYSIS 260

14.4.3 COMPANY SHARE ANALYSIS 260

14.4.4 PRODUCT PORTFOLIO 261

14.4.5 RECENT DEVELOPMENTS 261

14.5 RANDOX LABORATORIES LTD. 262

14.5.1 COMPANY SNAPSHOT 262

14.5.2 PRODUCT PORTFOLIO 262

14.5.3 RECENT DEVELOPMENT 262

14.6 AGILENT TECHNOLOGIES, INC. 263

14.6.1 COMPANY SNAPSHOT 263

14.6.2 REVENUE ANALYSIS 263

14.6.3 PRODUCT PORTFOLIO 264

14.6.4 RECENT DEVELOPMENT 264

14.7 LUMINEX CORPORATION 265

14.7.1 COMPANY SNAPSHOT 265

14.7.2 REVENUE ANALYSIS 265

14.7.3 PRODUCT PORTFOLIO 266

14.7.4 RECENT DEVELOPMENT 266

14.8 BD 267

14.8.1 COMPANY SNAPSHOT 267

14.8.2 REVENUE ANALYSIS 268

14.8.3 PRODUCT PORTFOLIO 268

14.8.4 RECENT DEVELOPMENT 269

14.9 BECKMAN COULTER, INC. 270

14.9.1 COMPANY SNAPSHOT 270

14.9.2 REVENUE ANALYSIS 271

14.9.3 PRODUCT PORTFOLIO 271

14.9.4 RECENT DEVELOPMENT 272

14.10 BIOCHECK, INC. 273

14.10.1 COMPANY SNAPSHOT 273

14.10.2 PRODUCT PORTFOLIO 273

14.10.3 RECENT DEVELOPMENT 274

14.11 BIO-TECHNE 275

14.11.1 COMPANY SNAPSHOT 275

14.11.2 REVENUE ANALYSIS 276

14.11.3 PRODUCT PORTFOLIO 276

14.11.4 RECENT DEVELOPMENTS 278

14.12 DIASORIN S.P.A. 279

14.12.1 COMPANY SNAPSHOT 279

14.12.2 PRODUCT PORTFOLIO 279

14.12.3 RECENT DEVELOPMENTS 280

14.13 MERCK KGAA 281

14.13.1 COMPANY SNAPSHOT 281

14.13.2 REVENUE ANALYSIS 282

14.13.3 PRODUCT PORTFOLIO 282

14.13.4 RECENT DEVELOPMENTS 284

14.14 MESO SCALE DIAGNOSTICS, LLC 285

14.14.1 COMPANY SNAPSHOT 285

14.14.2 PRODUCT PORTFOLIO 285

14.14.3 RECENT DEVELOPMENTS 288

14.15 ORTHO CLINICAL DIAGNOSTICS (A SUBSIDIARY OF CARLYLE INVESTMENT MANAGEMENT L.L.C) 289

14.15.1 COMPANY SNAPSHOT 289

14.15.2 REVENUE ANALYSIS 289

14.15.3 PRODUCT PORTFOLIO 290

14.15.4 RECENT DEVELOPMENT 290

14.16 PERKINELMER INC. 291

14.16.1 COMPANY SNAPSHOT 291

14.16.2 REVENUE ANALYSIS 292

14.16.3 PRODUCT PORTFOLIO 292

14.16.4 RECENT DEVELOPMENT 293

14.17 QIAGEN 294

14.17.1 COMPANY SNAPSHOT 294

14.17.2 REVENUE ANALYSIS 295

14.17.3 PRODUCT PORTFOLIO 295

14.17.4 RECENT DEVELOPMENT 296

14.18 QUIDEL CORPORATION 297

14.18.1 COMPANY SNAPSHOT 297

14.18.2 REVENUE ANALYSIS 298

14.18.3 PRODUCT PORTFOLIO 298

14.18.4 RECENT DEVELOPMENT 301

14.19 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. 302

14.19.1 COMPANY SNAPSHOT 302

14.19.2 PRODUCT PORTFOLIO 302

14.19.3 RECENT DEVELOPMENTS 303

14.20 SIEMENS 304

14.20.1 COMPANY SNAPSHOT 304

14.20.2 REVENUE ANALYSIS 304

14.20.3 PRODUCT PORTFOLIO 305

14.20.4 RECENT DEVELOPMENTS 305

14.21 SYSMEX CORPORATION 306

14.21.1 COMPANY SNAPSHOT 306

14.21.2 REVENUE ANALYSIS 307

14.21.3 PRODUCT PORTFOLIO 307

14.21.4 RECENT DEVELOPMENTS 307

14.22 THERMO FISHER SCIENTIFIC INC. 309

14.22.1 COMPANY SNAPSHOT 309

14.22.2 REVENUE ANALYSIS 309

14.22.3 PRODUCT PORTFOLIO 310

14.22.4 RECENT DEVELOPMENTS 311

15 QUESTIONNAIRE 312

16 RELATED REPORTS 316